Src inhibitor

Src inhibitors are pharmaceutical compounds that specifically target and inhibit the activity of Src kinases, a family of non-receptor tyrosine kinases involved in cellular signaling pathways. Src kinases play crucial roles in regulating processes such as cell growth, proliferation, differentiation, adhesion, and migration. They are implicated in various signaling networks, including those mediated by growth factor receptors, integrins, and other cell surface receptors. By inhibiting Src kinases, Src inhibitors interfere with these signaling cascades, leading to impaired cellular functions that are vital for cancer cell survival and proliferation. Src inhibitors have shown therapeutic potential in treating cancers where Src kinase activity is dysregulated, such as colorectal cancer, breast cancer, and non-small cell lung cancer.